Team Leader: Dr. Stephen Mirembe Kizito (HoD)
Title: XERODERMA PIGMENTOSA: CLINICAL ADVANCES AND MANAGEMENT.
Subtitles: Challenges in diagnosis and management. Prognosis and Role of multidisciplinary care.
The session will be chaired by Dr. Mirembe Stephen Kizito, lecturer and HOD –Dermatology
Target audience: All healthcare professionals and medical students
Learning outcomes; Diagnostic criteria, management options and interdisciplinary approach to XP management.
Over View : Xeroderma pigmentosa is a rare inherited autosomal recessive disease with the inability to repair DNA damage caused by UV light. It has been reported worldwide and in all races with an overall prevalence of 1-4 per million populations. Those affected are extremely sensitive to the UV portion of the light and have a 2000-fold increased risk of skin cancer in the sun exposed skin. Basal cell carcinoma is the most commonly associated carcinoma followed by Squamous cell carcinoma and Melanoma. The pigmentation on the face and the rest of the body can be horribly disfiguring. The recurring cancer occurring on the face and repeated surgical treatment for the ulcerations have important social and psychological implications not encountered with other cancers
In addition to the cutaneous and psychosocial effects, XP also has neurological and ophthalmologic sequalae requiring a multidisciplinary approach to its management.
Recent advances in dermatotherapy provide a wide range of treatment options; including laser, cryotherapy, interferon therapy, gene therapy and photodynamic therapy so as to improve quality of life and survival.
Structure:
Introduction: Dr. Gladys Aloyo/ moderator
Case presentation 1: Dr. Shaban Moshi
Case Presentation 2: Dr. Miria Cherop
Case Discussion: Dr. Maliro Amos
Conclusion: Dr. Mohamed
Q&A session: All Presenters
Vote of Thanks: Dr. Gladys
